[Adjuvant treatment in operable colonic and rectal cancer. A new possibility].
Tveit
K M
KM
Norsk Gastrointestinal Cancer Gruppe, Onkologisk avdeling, Ullevål sykehus, Oslo.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000601:surgery*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage*; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*
D000276:Adjuvants, Immunologic; D000964:Antimetabolites, Antineoplastic; D007978:Levamisole; D005472:Fluorouracil